Navigation Links
Kensey Nash Announces New Unsecured Revolving Credit Facility
Date:5/26/2011

EXTON, Pa., May 26, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) announced today that it has entered into a new $35 million unsecured revolving credit facility with Wells Fargo Bank, National Association.

The new credit facility has a term of three years, maturing on May 25, 2014, with the option to extend it up to two additional one year periods upon meeting certain conditions. The credit facility allows the Company to use borrowings for working capital purposes and general corporate purposes including permitted acquisitions and capital expenditures. Borrowings under the revolving credit facility will, at the Company's option, bear interest at a rate of either London Inter Bank Offering Rate ("LIBOR") plus an applicable margin, or Prime Rate plus an applicable margin. Based on this week's 1-month LIBOR rate, borrowings on this facility would bear interest in the range of 1.20% to 1.65%.

"The availability of this new credit facility provides us the flexibility to be able to execute our growth plans at attractive rates and enhances our liquidity position," said Michael Celano, CFO of Kensey Nash.

About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology.  The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials.  The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Kensey Nash to Present at the Jefferies 2011 Global Healthcare Conference
2. Kensey Nash Corporation Announces Its Third Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
3. Kensey Nash to Present at the Canaccord Genuity Musculoskeletal Conference
4. Kensey Nash Corporation Announces Its Second Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
5. Kensey Nash Announces a Manufacturing Agreement with and Minority Investment in Orteq Sports Medicine
6. Kensey Nash and Arthrex Announce European Distribution Agreement for the Cartilage Repair Device
7. Kensey Nash to Present at Two Investor Conferences in November
8. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
9. Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results
10. Kensey Nash Corporation Announces Its Fourth Quarter and Fiscal Year End 2010 Earnings Release Date and Teleconference
11. Kensey Nash to Present at the Jefferies 2010 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... March 27, 2017 Summary ... understand Bayer and its partnering interests and activities since 2010. ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ... The report will be delivered in PDF format ...
(Date:3/27/2017)... , March 27, 2017  A recent study ... only four freestanding hospitals in the country dedicated to ... and reconstructive surgery, concluded that the Surfacide Helios ® ... integral component in reducing bacterial pathogens not killed by ... were published at the American Burn Association,s 49th Annual ...
(Date:3/27/2017)... March 27, 2017 LightIntegra Technology Inc. today ... "Bill" Dubiel as President and Chief Executive Officer effective ... the Board of Directors of LightIntegra. Paul Geyer ... of LightIntegra. "This is the perfect ... Chief Executive Officer. We,ve selected a very strong leader ...
Breaking Medicine Technology:
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... ... for and by physicians, announced today the launch of a free, public-facing tool ... Via Cost Analyzer (VCA) was developed to provide comparative information to patients, providers, ...
(Date:3/28/2017)... ... , ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; ... scientists will speak to the press on behalf of over 200 doctors, scientists, and ... safety commission. , WHERE: , Zenger Room, National Press Club, 529 14th Street ...
(Date:3/28/2017)... Switzerland (PRWEB) , ... March 28, 2017 , ... ... for laboratory instruments are critical to ensuring high-quality results and maintaining GMP and ... Qualification of Laboratory Instruments in accordance with GMP requirements " these requirements are ...
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology , a provider ... and attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and ... biometric face recognition to enable users to check in and out from anywhere ...
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
Breaking Medicine News(10 mins):